Načítá se...
HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer
Prostate cancer (CaP) is the most common cancer among adult men in the Western world. Better insight into its tumor-activating pathways may facilitate the development of targeted therapies. In this study, we show that patients who develop prostate tumors with low levels of PTEN and high levels of HE...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
National Academy of Sciences
2011
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3182686/ https://ncbi.nlm.nih.gov/pubmed/21930937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1101263108 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|